DMNQ-S17 inhibits constitutive NF-kappaB activation leading to induction of apoptosis through the activation of caspase-3 in human myeloid leukemia U937 cells

Life Sciences
Min-Jong ParkSung-Hoon Kim

Abstract

Through cytotoxicity screening with naphthoquinone derivatives, a novel compound 6-(1-oxoallkyl)-5,8-dimethoxy-1,4-naphthoquinone-S17 (DMNQ-S17) showed its potency against human myeloid leukemia U937 cells. Thus, to elucidate the apoptotic mechanism of DMNQ-S17, this study was performed in myeloid leukemia U937 cells by 2,3-bis [2-methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide (XTT) assay, eletrophoretic mobility shift assay (EMSA), terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) assay, 4',6-diamidino-2-phenylindole (DAPI) staining, and Western blotting. In the present study, DMNQ-S17 inhibited constitutive NF kappaB activation and its transcriptional activity in U937 cells. In addition, DMNQ-S17 induced apoptotic features such as apoptotic bodies, cell shrinkage and chromatin condensation in U937 cells. Consistently, flow cytometric analysis showed that DMNQ-S17 increased sub-G1 portion and TUNEL positive cells in a concentration-dependent manner. Furthermore, DMNQ-S17 effectively attenuated mitochondrial membrane potential, released cytochrome C, activated caspase-3 expression, and cleaved poly (ADP-ribose) polymerase (PARP). Reversely, caspase-3 and -9 inhibitors also blocked the ...Continue Reading

References

Jul 1, 1986·Annals of Internal Medicine·T D Shenkenberg, D D Von Hoff
Dec 11, 1994·Nucleic Acids Research·M HerrmannJ R Kalden
Feb 7, 1997·Cell·M D JacobsonM C Raff
Mar 31, 2000·Experimental Cell Research·M BamfordR Brown
Mar 31, 2000·Experimental Cell Research·S H Kaufmann, W C Earnshaw
Dec 31, 2003·Biochemical and Biophysical Research Communications·Akiko YamakiYoshiko Shimizu
May 25, 2005·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·David W KohValina L Dawson
Jun 9, 2005·Cell Biology International·Zi-Bing WangYu-Fang Cui
Jan 3, 2006·Annals of the New York Academy of Sciences·Kwang Seok Ahn, Bharat B Aggarwal
Jun 23, 2006·Medicinal Chemistry·K KuwanoY Nakanishi
Nov 25, 2006·Hematology·Francesco Lo-Coco, Emanuele Ammatuna
Apr 4, 2007·Annals of the New York Academy of Sciences·Eu-Soo LimSung-Hoon Kim
Oct 9, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J L Fernández-Luna
Oct 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Domagoj Vucic, Wayne J Fairbrother
Nov 16, 2007·Current Treatment Options in Oncology·Aaron D Schimmer
Jan 23, 2008·Biochemical Society Transactions·Susan E Logue, Seamus J Martin

❮ Previous
Next ❯

Citations

May 30, 2014·The American Journal of Chinese Medicine·Chao-Yun WangChun-Hua Wang
Oct 6, 2010·Leukemia & Lymphoma·Mariano ProvencioCarmen Bellas
May 6, 2016·International Journal of Molecular Sciences·Sun-Hyung HaCheorl-Ho Kim
Jan 14, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Li-Min LiKe Zen
Oct 6, 2009·Archives of Biochemistry and Biophysics·Xiao-Mei ZhuZhi-Yong Sheng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis